Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery
Clinical trial NCT01856998 · COMPLETED
Trial details
- NCT number
- NCT01856998
- Sponsor
- Fresenius Kabi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-02-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.